Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - IDERA PHARMACEUTICALS, INC. | b84116exv31w2.htm |
| EX-32.1 - EX-32.1 - IDERA PHARMACEUTICALS, INC. | b84116exv32w1.htm |
| EX-32.2 - EX-32.2 - IDERA PHARMACEUTICALS, INC. | b84116exv32w2.htm |
| EX-31.1 - EX-31.1 - IDERA PHARMACEUTICALS, INC. | b84116exv31w1.htm |
| EX-10.14 - EX-10.14 - IDERA PHARMACEUTICALS, INC. | b84116exv10w14.htm |
| EX-10.41 - EX-10.41 - IDERA PHARMACEUTICALS, INC. | b84116exv10w41.htm |
| 10-K - IDERA PHARMACEUTICALS, INC. - IDERA PHARMACEUTICALS, INC. | b84116e10vk.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos.
333-3896, 333-3898, 333-3900, 333-3902, 333-34008, 333-71938, 333-116010, 333-116011, 333-116012,
333-126664, 333-137687, 333-137688, 333-147474, 333-152669, and 333-152670, Form S-1 as amended by
Form S-3/A No. 333-136610, Form S-2 as amended by Form S-3/A No. 333-109630 and Form S-3 Nos.
333-111903, 333-119943, 333-126634, 333-131804, 333-133455, 333-133456, 333-139830 and 333-169060)
and in the related Prospectuses of Idera Pharmaceuticals, Inc. of our reports dated March 10, 2011
with respect to the financial statements of Idera Pharmaceuticals, Inc. and the effectiveness of
internal control over financial reporting of Idera Pharmaceuticals, Inc. included in this Annual
Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 10, 2011
March 10, 2011